Ohio-Bound

High-tech startups are popping up in unexpected cities, reports the Wall Street Journal. Instead of flocking to Boston or the Bay Area, companies are opening up or remaining in Ohio and Michigan. The founder of Proxy Biomedical Peter Gingras, based in Galway, Ireland, turned to Cleveland to open his US-based operations. "The State of Ohio, the City of Cleveland and the Cleveland Clinic stepped up and put a competitive package together. In the end, it was an easy decision," Gingras says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.